Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines

The isoquinolinamine FX-9 is a novel potential chemotherapeutic agent showing antiproliferative effects against hematologic and prostate cancer cell lines such as B- and T-acute lymphoblastic leukemia and prostate cancer (PC) of different species. Interestingly, FX-9 shows no hemolytic activity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiner, Franziska, Schille, Jan Torben, Hein, Jens Ingo, Wu, Xiao-Feng, Beller, Matthias, Junghanß, Christian, Murua Escobar, Hugo, Nolte, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386839/
https://www.ncbi.nlm.nih.gov/pubmed/34432846
http://dx.doi.org/10.1371/journal.pone.0256468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386839/
https://www.ncbi.nlm.nih.gov/pubmed/34432846
http://dx.doi.org/10.1371/journal.pone.0256468

Ejemplares similares